Although it is difficult to use TRAIL as a chemopreventive agent for human cancers, it will be possible to screen for drugs that activate TRAIL receptor signaling to induce the apoptosis and remove the damaged cells [45]. The gene discussed is TNFSF10; the disease is cancer.